

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.20961371 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.17908824 |
| 3 | low-density lipoprotein particle remodeling (GO:0034374) | 4.64524564 |
| 4 | glutamate secretion (GO:0014047) | 4.61520848 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.32601499 |
| 6 | postsynaptic membrane organization (GO:0001941) | 4.28923309 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.10454278 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.06636491 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.03127713 |
| 10 | potassium ion homeostasis (GO:0055075) | 3.99416235 |
| 11 | cellular response to cholesterol (GO:0071397) | 3.90095381 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.86707988 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.79132909 |
| 14 | astrocyte differentiation (GO:0048708) | 3.74539170 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.72496742 |
| 16 | central nervous system myelination (GO:0022010) | 3.71999084 |
| 17 | axon ensheathment in central nervous system (GO:0032291) | 3.71999084 |
| 18 | L-serine transport (GO:0015825) | 3.70230786 |
| 19 | neuronal action potential propagation (GO:0019227) | 3.67369452 |
| 20 | cellular modified amino acid catabolic process (GO:0042219) | 3.65037222 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.64856970 |
| 22 | alanine transport (GO:0032328) | 3.63498062 |
| 23 | neurotransmitter uptake (GO:0001504) | 3.57505802 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 3.57421829 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 3.54972001 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.51039850 |
| 27 | C4-dicarboxylate transport (GO:0015740) | 3.49924402 |
| 28 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.49836157 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 3.46133624 |
| 30 | ovulation cycle (GO:0042698) | 3.43193574 |
| 31 | negative regulation of astrocyte differentiation (GO:0048712) | 3.39494072 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 3.36189010 |
| 33 | cellular response to sterol (GO:0036315) | 3.35872305 |
| 34 | cholesterol catabolic process (GO:0006707) | 3.34970663 |
| 35 | sterol catabolic process (GO:0016127) | 3.34970663 |
| 36 | cell communication by electrical coupling (GO:0010644) | 3.34917503 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 3.34679464 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 3.31694854 |
| 39 | macromolecular complex remodeling (GO:0034367) | 3.31694854 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31694854 |
| 41 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.26996338 |
| 42 | sodium ion export (GO:0071436) | 3.26376320 |
| 43 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.24047478 |
| 44 | vocalization behavior (GO:0071625) | 3.23748705 |
| 45 | astrocyte development (GO:0014002) | 3.22892558 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.21948074 |
| 47 | L-serine metabolic process (GO:0006563) | 3.20637583 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 3.20190676 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.20058221 |
| 50 | * reverse cholesterol transport (GO:0043691) | 3.19241769 |
| 51 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.18282645 |
| 52 | presynaptic membrane organization (GO:0097090) | 3.16629164 |
| 53 | cerebellar Purkinje cell layer development (GO:0021680) | 3.16177608 |
| 54 | response to auditory stimulus (GO:0010996) | 3.15969573 |
| 55 | neuronal ion channel clustering (GO:0045161) | 3.15265850 |
| 56 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.14952307 |
| 57 | serine transport (GO:0032329) | 3.13909765 |
| 58 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.12413149 |
| 59 | neuron cell-cell adhesion (GO:0007158) | 3.09919526 |
| 60 | lung epithelium development (GO:0060428) | 3.08960106 |
| 61 | cysteine metabolic process (GO:0006534) | 3.08486760 |
| 62 | chondroitin sulfate catabolic process (GO:0030207) | 3.08452230 |
| 63 | negative regulation of sodium ion transport (GO:0010766) | 3.08381184 |
| 64 | linoleic acid metabolic process (GO:0043651) | 3.08358786 |
| 65 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.05473080 |
| 66 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.03104980 |
| 67 | neurotransmitter transport (GO:0006836) | 3.02224636 |
| 68 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.00724651 |
| 69 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.00458571 |
| 70 | exploration behavior (GO:0035640) | 2.98399213 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97219458 |
| 72 | L-phenylalanine catabolic process (GO:0006559) | 2.97219458 |
| 73 | glutamate metabolic process (GO:0006536) | 2.93332008 |
| 74 | very long-chain fatty acid metabolic process (GO:0000038) | 2.92813931 |
| 75 | regulation of neurotransmitter levels (GO:0001505) | 2.92182689 |
| 76 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.90447546 |
| 77 | gap junction assembly (GO:0016264) | 2.89165357 |
| 78 | amino acid import (GO:0043090) | 2.85806312 |
| 79 | plasma lipoprotein particle organization (GO:0071827) | 2.84890539 |
| 80 | keratan sulfate catabolic process (GO:0042340) | 2.84285195 |
| 81 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.83840967 |
| 82 | regulation of neurotransmitter uptake (GO:0051580) | 2.83541792 |
| 83 | positive regulation of synapse maturation (GO:0090129) | 2.83090418 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.82807492 |
| 85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.81816079 |
| 86 | L-phenylalanine metabolic process (GO:0006558) | 2.81816079 |
| 87 | response to leptin (GO:0044321) | 2.79936157 |
| 88 | L-amino acid import (GO:0043092) | 2.79411150 |
| 89 | response to nitrosative stress (GO:0051409) | 2.78487599 |
| 90 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.75664684 |
| 91 | purine nucleotide transport (GO:0015865) | 2.75624090 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 2.75008342 |
| 93 | dicarboxylic acid catabolic process (GO:0043649) | 2.74533546 |
| 94 | adenine nucleotide transport (GO:0051503) | 2.74243121 |
| 95 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.74166247 |
| 96 | regulation of synapse structural plasticity (GO:0051823) | 2.73631012 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.73567841 |
| 98 | cellular sodium ion homeostasis (GO:0006883) | 2.73119932 |
| 99 | gonadal mesoderm development (GO:0007506) | 2.73023635 |
| 100 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72927238 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 2.72654576 |
| 102 | acidic amino acid transport (GO:0015800) | 2.72523874 |
| 103 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.71942909 |
| 104 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71265247 |
| 105 | ethanol oxidation (GO:0006069) | 2.71209770 |
| 106 | regulation of neurotransmitter transport (GO:0051588) | 2.69255881 |
| 107 | synaptic transmission, glutamatergic (GO:0035249) | 2.68683209 |
| 108 | neuromuscular process controlling posture (GO:0050884) | 2.68130201 |
| 109 | long-term synaptic potentiation (GO:0060291) | 2.67600753 |
| 110 | amino-acid betaine metabolic process (GO:0006577) | 2.67231777 |
| 111 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.65455610 |
| 112 | response to dietary excess (GO:0002021) | 2.64752397 |
| 113 | regulation of synaptic plasticity (GO:0048167) | 2.64505343 |
| 114 | protein-lipid complex subunit organization (GO:0071825) | 2.62297120 |
| 115 | synaptic vesicle endocytosis (GO:0048488) | 2.62072310 |
| 116 | dendritic spine morphogenesis (GO:0060997) | 2.61975866 |
| 117 | purine ribonucleotide transport (GO:0015868) | 2.61655711 |
| 118 | regulation of neurotransmitter secretion (GO:0046928) | 2.61501326 |
| 119 | locomotory exploration behavior (GO:0035641) | 2.60147478 |
| 120 | * glial cell proliferation (GO:0014009) | 2.59949169 |
| 121 | phospholipid efflux (GO:0033700) | 2.59197872 |
| 122 | positive regulation of membrane potential (GO:0045838) | 2.57989008 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 2.57683914 |
| 124 | regulation of glomerular filtration (GO:0003093) | 2.57661420 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.56985833 |
| 126 | regulation of cholesterol metabolic process (GO:0090181) | 2.56474763 |
| 127 | neuromuscular process controlling balance (GO:0050885) | 2.55431172 |
| 128 | response to gravity (GO:0009629) | 2.54487941 |
| 129 | homocysteine metabolic process (GO:0050667) | 2.53773605 |
| 130 | aromatic amino acid family catabolic process (GO:0009074) | 2.53237843 |
| 131 | carnitine metabolic process (GO:0009437) | 2.53222327 |
| 132 | positive regulation of neurotransmitter transport (GO:0051590) | 2.52481478 |
| 133 | detection of calcium ion (GO:0005513) | 2.52283622 |
| 134 | bile acid biosynthetic process (GO:0006699) | 2.51828150 |
| 135 | cellular amino acid catabolic process (GO:0009063) | 2.50765590 |
| 136 | alpha-amino acid catabolic process (GO:1901606) | 2.50659959 |
| 137 | one-carbon compound transport (GO:0019755) | 2.49677022 |
| 138 | fructose metabolic process (GO:0006000) | 2.48090640 |
| 139 | sodium ion homeostasis (GO:0055078) | 2.47843057 |
| 140 | layer formation in cerebral cortex (GO:0021819) | 2.47600987 |
| 141 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.46829456 |
| 142 | protein localization to synapse (GO:0035418) | 2.45974335 |
| 143 | cellular response to leptin stimulus (GO:0044320) | 2.45841035 |
| 144 | lysine catabolic process (GO:0006554) | 2.45655323 |
| 145 | lysine metabolic process (GO:0006553) | 2.45655323 |
| 146 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.45594859 |
| 147 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.45018140 |
| 148 | cell communication involved in cardiac conduction (GO:0086065) | 2.44751168 |
| 149 | potassium ion import (GO:0010107) | 2.44633468 |
| 150 | regulation of astrocyte differentiation (GO:0048710) | 2.44238337 |
| 151 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.43164623 |
| 152 | L-glutamate transport (GO:0015813) | 2.42980003 |
| 153 | regulation of ARF protein signal transduction (GO:0032012) | 2.42364245 |
| 154 | kynurenine metabolic process (GO:0070189) | 2.42127175 |
| 155 | neuron projection regeneration (GO:0031102) | 2.41767638 |
| 156 | macroautophagy (GO:0016236) | 2.41207510 |
| 157 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.40949829 |
| 158 | auditory behavior (GO:0031223) | 2.40555455 |
| 159 | regulation of respiratory system process (GO:0044065) | 2.39837484 |
| 160 | negative regulation of complement activation (GO:0045916) | 2.39258368 |
| 161 | eye photoreceptor cell differentiation (GO:0001754) | 2.39146026 |
| 162 | photoreceptor cell differentiation (GO:0046530) | 2.39146026 |
| 163 | regulation of female receptivity (GO:0045924) | 2.38654199 |
| 164 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.38447906 |
| 165 | positive regulation of dendritic spine development (GO:0060999) | 2.38178109 |
| 166 | positive regulation of male gonad development (GO:2000020) | 2.37761856 |
| 167 | neurotransmitter catabolic process (GO:0042135) | 2.37009329 |
| 168 | membrane repolarization (GO:0086009) | 2.35952724 |
| 169 | protein-lipid complex assembly (GO:0065005) | 2.35103238 |
| 170 | regulation of apoptotic cell clearance (GO:2000425) | 2.34451927 |
| 171 | gamma-aminobutyric acid transport (GO:0015812) | 2.34348583 |
| 172 | glutamate receptor signaling pathway (GO:0007215) | 2.34336421 |
| 173 | regulation of complement activation (GO:0030449) | 2.34099458 |
| 174 | sex differentiation (GO:0007548) | 2.33847417 |
| 175 | lens fiber cell development (GO:0070307) | 2.33594151 |
| 176 | valine metabolic process (GO:0006573) | 2.33530682 |
| 177 | serine family amino acid biosynthetic process (GO:0009070) | 2.33420066 |
| 178 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.32931991 |
| 179 | artery smooth muscle contraction (GO:0014824) | 2.32929283 |
| 180 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.32501181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.32244754 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01865682 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67260444 |
| 4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.63844944 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57607273 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.22211863 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03937812 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96813167 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91946088 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91337980 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89623239 |
| 12 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88540524 |
| 13 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84358536 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.83541171 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79953902 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79673622 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78661502 |
| 18 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.76398325 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76011350 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73531995 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71328014 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70801493 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67552550 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66899777 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66837428 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.64841436 |
| 27 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62620110 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61268081 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58018088 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56400918 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55927041 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55927041 |
| 33 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48587306 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48491639 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47336058 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45549622 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41193036 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38565961 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37978282 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37110700 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33481954 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33232746 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32705220 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29779289 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24839163 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24839163 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23015647 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22836911 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21560163 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21080902 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20324546 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19580125 |
| 53 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19561852 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19559401 |
| 55 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19390089 |
| 56 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16667157 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13843074 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12670531 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12585322 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11645199 |
| 61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08877884 |
| 62 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08560316 |
| 63 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.08202113 |
| 64 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.07963318 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07721168 |
| 66 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.07584486 |
| 67 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05912647 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05061317 |
| 69 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01895759 |
| 70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00296245 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99509778 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.98959141 |
| 73 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98344254 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.97767889 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97531911 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97370497 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96864862 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96504413 |
| 79 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95302431 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94718539 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94663995 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94120342 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93220897 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92453406 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92419942 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91967704 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91872344 |
| 88 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90536771 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90390268 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89647190 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89393312 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89346741 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.89317626 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89215994 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88476428 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88406842 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87832838 |
| 98 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86998974 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86919319 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86826458 |
| 101 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86323579 |
| 102 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85792426 |
| 103 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.83717713 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83408733 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83140787 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82782579 |
| 107 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82633120 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82509917 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82395461 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81946650 |
| 111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81923163 |
| 112 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81420735 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81123352 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.81056363 |
| 115 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80216323 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79864275 |
| 117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79397976 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 0.79368170 |
| 119 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.79176390 |
| 120 | AR_19668381_ChIP-Seq_PC3_Human | 0.79109753 |
| 121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.79062037 |
| 122 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.78521495 |
| 123 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.78248253 |
| 124 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.76696857 |
| 125 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76327837 |
| 126 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.75975998 |
| 127 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75757053 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75600384 |
| 129 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.75426433 |
| 130 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.75386560 |
| 131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75216666 |
| 132 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73199501 |
| 133 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.73053276 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.69963388 |
| 135 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.68938428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.31960052 |
| 2 | MP0004858_abnormal_nervous_system | 3.59514644 |
| 3 | MP0002254_reproductive_system_inflammat | 3.55393763 |
| 4 | MP0003880_abnormal_central_pattern | 3.49522248 |
| 5 | MP0003690_abnormal_glial_cell | 3.26135803 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.15895175 |
| 7 | MP0003011_delayed_dark_adaptation | 2.87667860 |
| 8 | MP0005365_abnormal_bile_salt | 2.85594448 |
| 9 | MP0005360_urolithiasis | 2.78579242 |
| 10 | MP0003878_abnormal_ear_physiology | 2.78022515 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 2.78022515 |
| 12 | MP0009384_cardiac_valve_regurgitation | 2.72821211 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.69440917 |
| 14 | MP0009840_abnormal_foam_cell | 2.64019279 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.62648652 |
| 16 | MP0003195_calcinosis | 2.47329203 |
| 17 | MP0002272_abnormal_nervous_system | 2.31004413 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.27929484 |
| 19 | MP0005332_abnormal_amino_acid | 2.25154972 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.24643754 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.19097459 |
| 22 | MP0005503_abnormal_tendon_morphology | 2.16605875 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.10830308 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.99930107 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96628230 |
| 26 | * MP0003329_amyloid_beta_deposits | 1.94357420 |
| 27 | MP0001970_abnormal_pain_threshold | 1.89676043 |
| 28 | MP0004885_abnormal_endolymph | 1.88848398 |
| 29 | MP0004859_abnormal_synaptic_plasticity | 1.88121524 |
| 30 | MP0000920_abnormal_myelination | 1.86063214 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.85976668 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.83774341 |
| 33 | MP0003252_abnormal_bile_duct | 1.76902572 |
| 34 | MP0002736_abnormal_nociception_after | 1.74339574 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.73253232 |
| 36 | MP0005647_abnormal_sex_gland | 1.70767766 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.67105752 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.66369620 |
| 39 | MP0003075_altered_response_to | 1.64133151 |
| 40 | MP0005083_abnormal_biliary_tract | 1.61658471 |
| 41 | MP0002090_abnormal_vision | 1.57240740 |
| 42 | MP0001905_abnormal_dopamine_level | 1.54256594 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.52328072 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.46217544 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.45920007 |
| 46 | MP0000566_synostosis | 1.35144381 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.33931033 |
| 48 | MP0003279_aneurysm | 1.32369287 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.29613131 |
| 50 | MP0003122_maternal_imprinting | 1.26066555 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.26024388 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.25941537 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.23090119 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.20787625 |
| 55 | MP0003634_abnormal_glial_cell | 1.20249492 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.18610939 |
| 57 | * MP0000604_amyloidosis | 1.16291677 |
| 58 | MP0000778_abnormal_nervous_system | 1.15954701 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.15543245 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.15002289 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.14723940 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.13951540 |
| 63 | MP0001984_abnormal_olfaction | 1.12522234 |
| 64 | MP0001958_emphysema | 1.10982488 |
| 65 | MP0001756_abnormal_urination | 1.10568970 |
| 66 | MP0005165_increased_susceptibility_to | 1.10500344 |
| 67 | MP0003635_abnormal_synaptic_transmissio | 1.10120873 |
| 68 | * MP0003632_abnormal_nervous_system | 1.09885212 |
| 69 | MP0002168_other_aberrant_phenotype | 1.08743110 |
| 70 | MP0008995_early_reproductive_senescence | 1.08552158 |
| 71 | MP0003633_abnormal_nervous_system | 1.08434977 |
| 72 | MP0004272_abnormal_basement_membrane | 1.06950709 |
| 73 | MP0003879_abnormal_hair_cell | 1.06922240 |
| 74 | MP0001486_abnormal_startle_reflex | 1.06323108 |
| 75 | MP0002653_abnormal_ependyma_morphology | 1.06322006 |
| 76 | MP0002229_neurodegeneration | 1.05511172 |
| 77 | * MP0002882_abnormal_neuron_morphology | 1.04938750 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 1.03393085 |
| 79 | MP0001881_abnormal_mammary_gland | 0.99622576 |
| 80 | MP0005166_decreased_susceptibility_to | 0.99422923 |
| 81 | MP0000955_abnormal_spinal_cord | 0.98265581 |
| 82 | MP0001664_abnormal_digestion | 0.96721402 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.96292739 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.95562004 |
| 85 | MP0003045_fibrosis | 0.94746582 |
| 86 | * MP0003631_nervous_system_phenotype | 0.94019993 |
| 87 | MP0005275_abnormal_skin_tensile | 0.93080165 |
| 88 | MP0003868_abnormal_feces_composition | 0.93063579 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93016954 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 0.92739325 |
| 91 | MP0002063_abnormal_learning/memory/cond | 0.92690888 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.92427046 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.92425030 |
| 94 | MP0002064_seizures | 0.92027585 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.91673347 |
| 96 | MP0009745_abnormal_behavioral_response | 0.90930178 |
| 97 | MP0000609_abnormal_liver_physiology | 0.90856656 |
| 98 | MP0000751_myopathy | 0.89688094 |
| 99 | MP0003186_abnormal_redox_activity | 0.89584550 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.88801831 |
| 101 | MP0002928_abnormal_bile_duct | 0.88566253 |
| 102 | MP0004924_abnormal_behavior | 0.87313648 |
| 103 | MP0005386_behavior/neurological_phenoty | 0.87313648 |
| 104 | MP0005595_abnormal_vascular_smooth | 0.87161592 |
| 105 | MP0005535_abnormal_body_temperature | 0.86305480 |
| 106 | MP0003115_abnormal_respiratory_system | 0.85760933 |
| 107 | MP0008874_decreased_physiological_sensi | 0.84958246 |
| 108 | MP0001661_extended_life_span | 0.84386448 |
| 109 | MP0005670_abnormal_white_adipose | 0.82422392 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.81180687 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.81073593 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.80224917 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.80076865 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.79741089 |
| 115 | MP0002152_abnormal_brain_morphology | 0.79090229 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.77903837 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.77875611 |
| 118 | MP0003787_abnormal_imprinting | 0.76123859 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.75919265 |
| 120 | MP0003136_yellow_coat_color | 0.74590761 |
| 121 | MP0005253_abnormal_eye_physiology | 0.71938563 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.71688728 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.70881474 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.70576334 |
| 125 | MP0008872_abnormal_physiological_respon | 0.70435727 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.69954619 |
| 127 | MP0004270_analgesia | 0.69790944 |
| 128 | MP0002069_abnormal_eating/drinking_beha | 0.69762170 |
| 129 | MP0002184_abnormal_innervation | 0.69427024 |
| 130 | MP0000579_abnormal_nail_morphology | 0.68891715 |
| 131 | MP0005410_abnormal_fertilization | 0.66730668 |
| 132 | MP0009764_decreased_sensitivity_to | 0.65586982 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.65378588 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.63022907 |
| 135 | MP0000747_muscle_weakness | 0.62537443 |
| 136 | MP0004130_abnormal_muscle_cell | 0.62234815 |
| 137 | MP0000013_abnormal_adipose_tissue | 0.61858607 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.61787476 |
| 139 | MP0004043_abnormal_pH_regulation | 0.61731607 |
| 140 | MP0002127_abnormal_cardiovascular_syste | 0.61720525 |
| 141 | MP0003942_abnormal_urinary_system | 0.61677333 |
| 142 | MP0008569_lethality_at_weaning | 0.61422718 |
| 143 | MP0003283_abnormal_digestive_organ | 0.61158877 |
| 144 | MP0004883_abnormal_blood_vessel | 0.60000614 |
| 145 | MP0009046_muscle_twitch | 0.59772677 |
| 146 | MP0001177_atelectasis | 0.58531849 |
| 147 | MP0000026_abnormal_inner_ear | 0.56498951 |
| 148 | MP0002108_abnormal_muscle_morphology | 0.54713055 |
| 149 | MP0001944_abnormal_pancreas_morphology | 0.54611625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Megalencephaly (HP:0001355) | 5.13377177 |
| 2 | Aplasia involving bones of the extremities (HP:0009825) | 5.10837993 |
| 3 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.10837993 |
| 4 | Aplasia of the phalanges of the hand (HP:0009802) | 5.10837993 |
| 5 | Action tremor (HP:0002345) | 4.73676141 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.53500671 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.10178412 |
| 8 | Onycholysis (HP:0001806) | 4.03265897 |
| 9 | Focal motor seizures (HP:0011153) | 3.78605139 |
| 10 | Back pain (HP:0003418) | 3.73520778 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 3.71900667 |
| 12 | Xanthomatosis (HP:0000991) | 3.44950999 |
| 13 | Hyperglycinuria (HP:0003108) | 3.41260998 |
| 14 | Focal seizures (HP:0007359) | 3.39568335 |
| 15 | Abnormal eating behavior (HP:0100738) | 3.34326184 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.30473811 |
| 17 | Clumsiness (HP:0002312) | 3.30373300 |
| 18 | Torticollis (HP:0000473) | 3.28290976 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.23774199 |
| 20 | Hypoplastic left heart (HP:0004383) | 3.17607720 |
| 21 | Abnormality of complement system (HP:0005339) | 3.16380809 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.15648755 |
| 23 | Glomerulonephritis (HP:0000099) | 3.11899778 |
| 24 | Hypoplasia of the uterus (HP:0000013) | 3.11150569 |
| 25 | Ankle clonus (HP:0011448) | 3.10646334 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.10021562 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.10021562 |
| 28 | Atonic seizures (HP:0010819) | 3.07440180 |
| 29 | Deep venous thrombosis (HP:0002625) | 3.05799200 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 2.99001198 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 2.97841238 |
| 32 | Gout (HP:0001997) | 2.96065745 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 2.95883761 |
| 34 | Hydroxyprolinuria (HP:0003080) | 2.95883761 |
| 35 | Febrile seizures (HP:0002373) | 2.91638509 |
| 36 | Intention tremor (HP:0002080) | 2.87134441 |
| 37 | Focal dystonia (HP:0004373) | 2.86020875 |
| 38 | Epileptic encephalopathy (HP:0200134) | 2.84777026 |
| 39 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.81054467 |
| 40 | Humeroradial synostosis (HP:0003041) | 2.79116661 |
| 41 | Synostosis involving the elbow (HP:0003938) | 2.79116661 |
| 42 | Mitral stenosis (HP:0001718) | 2.75242313 |
| 43 | Ketosis (HP:0001946) | 2.74484155 |
| 44 | Papilledema (HP:0001085) | 2.73852922 |
| 45 | Craniofacial dystonia (HP:0012179) | 2.72900812 |
| 46 | Ketoacidosis (HP:0001993) | 2.72642703 |
| 47 | Tetraplegia (HP:0002445) | 2.72070178 |
| 48 | Hemiplegia (HP:0002301) | 2.70892811 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.70214155 |
| 50 | Sensorimotor neuropathy (HP:0007141) | 2.70056661 |
| 51 | Anxiety (HP:0000739) | 2.62946851 |
| 52 | Postural tremor (HP:0002174) | 2.62829085 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.61335190 |
| 54 | Mutism (HP:0002300) | 2.60510373 |
| 55 | Hyperglycinemia (HP:0002154) | 2.60506887 |
| 56 | Abnormality of the axillary hair (HP:0100134) | 2.55860226 |
| 57 | Abnormality of secondary sexual hair (HP:0009888) | 2.55860226 |
| 58 | Nuclear cataract (HP:0100018) | 2.52587874 |
| 59 | Late onset (HP:0003584) | 2.51423529 |
| 60 | Hyperammonemia (HP:0001987) | 2.47953431 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.45886084 |
| 62 | Increased circulating renin level (HP:0000848) | 2.45358454 |
| 63 | Truncal ataxia (HP:0002078) | 2.45179503 |
| 64 | Male infertility (HP:0003251) | 2.43924639 |
| 65 | Sleep apnea (HP:0010535) | 2.43692201 |
| 66 | Increased CSF protein (HP:0002922) | 2.43131699 |
| 67 | Hemiparesis (HP:0001269) | 2.41876904 |
| 68 | Tetraparesis (HP:0002273) | 2.41839125 |
| 69 | Amyloidosis (HP:0011034) | 2.41354564 |
| 70 | Polyphagia (HP:0002591) | 2.40456370 |
| 71 | Bronchomalacia (HP:0002780) | 2.39837409 |
| 72 | Vascular calcification (HP:0004934) | 2.35958164 |
| 73 | Mesangial abnormality (HP:0001966) | 2.35187790 |
| 74 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.33348453 |
| 75 | Gonadal dysgenesis (HP:0000133) | 2.31275641 |
| 76 | Spastic gait (HP:0002064) | 2.31190700 |
| 77 | Depression (HP:0000716) | 2.25579526 |
| 78 | Status epilepticus (HP:0002133) | 2.25564031 |
| 79 | Absence seizures (HP:0002121) | 2.24946702 |
| 80 | Progressive cerebellar ataxia (HP:0002073) | 2.23997264 |
| 81 | Esophageal varix (HP:0002040) | 2.22193600 |
| 82 | Dysmetria (HP:0001310) | 2.18256719 |
| 83 | Hypoplastic heart (HP:0001961) | 2.18221751 |
| 84 | Rigidity (HP:0002063) | 2.18009213 |
| 85 | Abnormality of the dental pulp (HP:0006479) | 2.16954513 |
| 86 | Postural instability (HP:0002172) | 2.15103794 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 2.14882407 |
| 88 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.14268834 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.14177836 |
| 90 | Insomnia (HP:0100785) | 2.09832294 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.09223724 |
| 92 | Arterial tortuosity (HP:0005116) | 2.08003328 |
| 93 | Akinesia (HP:0002304) | 2.07339657 |
| 94 | Pseudobulbar signs (HP:0002200) | 2.06929356 |
| 95 | Limb dystonia (HP:0002451) | 2.05143231 |
| 96 | Hypoglycemic coma (HP:0001325) | 2.05033990 |
| 97 | Peripheral hypomyelination (HP:0007182) | 2.04452722 |
| 98 | Fragile nails (HP:0001808) | 2.03721341 |
| 99 | Dysdiadochokinesis (HP:0002075) | 2.03631638 |
| 100 | Absent hair (HP:0002298) | 2.03599655 |
| 101 | Delusions (HP:0000746) | 2.03523187 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 2.02632412 |
| 103 | Nephritis (HP:0000123) | 2.01856758 |
| 104 | Short hallux (HP:0010109) | 2.01792244 |
| 105 | Dialeptic seizures (HP:0011146) | 2.01457178 |
| 106 | Abnormality of the dental root (HP:0006486) | 2.01303339 |
| 107 | Taurodontia (HP:0000679) | 2.01303339 |
| 108 | Abnormality of permanent molar morphology (HP:0011071) | 2.01303339 |
| 109 | Purpura (HP:0000979) | 2.01063291 |
| 110 | Exercise-induced myalgia (HP:0003738) | 1.98501360 |
| 111 | Prolonged partial thromboplastin time (HP:0003645) | 1.98179834 |
| 112 | Facial shape deformation (HP:0011334) | 1.98010835 |
| 113 | Potter facies (HP:0002009) | 1.98010835 |
| 114 | Tubulointerstitial nephritis (HP:0001970) | 1.96880244 |
| 115 | Hypercortisolism (HP:0001578) | 1.96143521 |
| 116 | Scotoma (HP:0000575) | 1.95101383 |
| 117 | Turricephaly (HP:0000262) | 1.94740007 |
| 118 | Hyperthyroidism (HP:0000836) | 1.94540311 |
| 119 | Split foot (HP:0001839) | 1.94233841 |
| 120 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93811444 |
| 121 | Bradykinesia (HP:0002067) | 1.93299600 |
| 122 | Supranuclear gaze palsy (HP:0000605) | 1.93185196 |
| 123 | Complement deficiency (HP:0004431) | 1.93131251 |
| 124 | Abnormality of binocular vision (HP:0011514) | 1.92388118 |
| 125 | Diplopia (HP:0000651) | 1.92388118 |
| 126 | Abnormality of molar (HP:0011077) | 1.91111606 |
| 127 | Abnormality of molar morphology (HP:0011070) | 1.91111606 |
| 128 | Congenital malformation of the right heart (HP:0011723) | 1.90768297 |
| 129 | Double outlet right ventricle (HP:0001719) | 1.90768297 |
| 130 | Fibular aplasia (HP:0002990) | 1.90359646 |
| 131 | Mild short stature (HP:0003502) | 1.90248627 |
| 132 | Epileptiform EEG discharges (HP:0011182) | 1.89596311 |
| 133 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.88849720 |
| 134 | Hypercholesterolemia (HP:0003124) | 1.87446339 |
| 135 | Cerebral hypomyelination (HP:0006808) | 1.86964901 |
| 136 | Increased purine levels (HP:0004368) | 1.84254618 |
| 137 | Hyperuricemia (HP:0002149) | 1.84254618 |
| 138 | Vascular tortuosity (HP:0004948) | 1.83857508 |
| 139 | Hypobetalipoproteinemia (HP:0003563) | 1.82786987 |
| 140 | Annular pancreas (HP:0001734) | 1.82374314 |
| 141 | Stroke (HP:0001297) | 1.82120643 |
| 142 | Global brain atrophy (HP:0002283) | 1.80855009 |
| 143 | Scanning speech (HP:0002168) | 1.80528550 |
| 144 | Neonatal short-limb short stature (HP:0008921) | 1.79852531 |
| 145 | Joint hemorrhage (HP:0005261) | 1.77992717 |
| 146 | Growth hormone excess (HP:0000845) | 1.77865020 |
| 147 | Abnormality of purine metabolism (HP:0004352) | 1.77479260 |
| 148 | Hyperventilation (HP:0002883) | 1.76219631 |
| 149 | Fat malabsorption (HP:0002630) | 1.75733673 |
| 150 | Delayed CNS myelination (HP:0002188) | 1.75583848 |
| 151 | Mixed hearing impairment (HP:0000410) | 1.75353704 |
| 152 | Gonadotropin excess (HP:0000837) | 1.74961145 |
| 153 | Myokymia (HP:0002411) | 1.74114331 |
| 154 | Dementia (HP:0000726) | 1.73167255 |
| 155 | Visual hallucinations (HP:0002367) | 1.72831320 |
| 156 | Hypoplasia of dental enamel (HP:0006297) | 1.72741996 |
| 157 | EEG with generalized epileptiform discharges (HP:0011198) | 1.72686690 |
| 158 | Retinal atrophy (HP:0001105) | 1.72407707 |
| 159 | Atrioventricular block (HP:0001678) | 1.71721594 |
| 160 | Abnormality of the diencephalon (HP:0010662) | 1.71694326 |
| 161 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.70585044 |
| 162 | Adactyly (HP:0009776) | 1.68530560 |
| 163 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.68239782 |
| 164 | Abnormal sex determination (HP:0012244) | 1.67398549 |
| 165 | Sex reversal (HP:0012245) | 1.67398549 |
| 166 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65204459 |
| 167 | Apathy (HP:0000741) | 1.63552826 |
| 168 | Heart block (HP:0012722) | 1.60491366 |
| 169 | Truncus arteriosus (HP:0001660) | 1.60342769 |
| 170 | Spastic tetraparesis (HP:0001285) | 1.59428367 |
| 171 | Adrenal overactivity (HP:0002717) | 1.58891233 |
| 172 | Choreoathetosis (HP:0001266) | 1.58112816 |
| 173 | Hypsarrhythmia (HP:0002521) | 1.57297773 |
| 174 | Menorrhagia (HP:0000132) | 1.57092763 |
| 175 | Abnormality of the corticospinal tract (HP:0002492) | 1.57071822 |
| 176 | J-shaped sella turcica (HP:0002680) | 1.54521271 |
| 177 | Shallow orbits (HP:0000586) | 1.54433778 |
| 178 | Spinal cord compression (HP:0002176) | 1.53602412 |
| 179 | Hammertoe (HP:0001765) | 1.53164863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.09029599 |
| 2 | EPHA2 | 4.47628494 |
| 3 | EPHA4 | 3.40979884 |
| 4 | MARK1 | 3.14086900 |
| 5 | PHKG1 | 3.07156428 |
| 6 | PHKG2 | 3.07156428 |
| 7 | PAK6 | 2.95734561 |
| 8 | PRKD3 | 2.95607220 |
| 9 | SIK1 | 2.80971411 |
| 10 | TRIB3 | 2.68791528 |
| 11 | NTRK2 | 2.48388967 |
| 12 | UHMK1 | 2.33833681 |
| 13 | BCKDK | 1.99451711 |
| 14 | PTK6 | 1.84125339 |
| 15 | RIPK1 | 1.79373104 |
| 16 | ERN1 | 1.65234679 |
| 17 | NEK6 | 1.63858596 |
| 18 | PDK3 | 1.62793267 |
| 19 | PDK4 | 1.62793267 |
| 20 | ARAF | 1.57733466 |
| 21 | TYRO3 | 1.57449802 |
| 22 | PLK2 | 1.51869259 |
| 23 | NTRK3 | 1.51348047 |
| 24 | FER | 1.47318791 |
| 25 | MAP3K4 | 1.45407335 |
| 26 | MAP3K12 | 1.40664619 |
| 27 | MST4 | 1.26890771 |
| 28 | EPHA3 | 1.26328667 |
| 29 | MAP3K2 | 1.26259091 |
| 30 | FRK | 1.22788812 |
| 31 | PKN1 | 1.20510013 |
| 32 | GRK5 | 1.19646052 |
| 33 | DAPK2 | 1.19387095 |
| 34 | MAP3K9 | 1.13069296 |
| 35 | TNIK | 1.11807575 |
| 36 | SGK494 | 1.09611536 |
| 37 | SGK223 | 1.09611536 |
| 38 | SGK2 | 1.08920893 |
| 39 | MYLK | 1.07957957 |
| 40 | MUSK | 1.03782655 |
| 41 | PAK3 | 1.03525974 |
| 42 | MAP2K7 | 1.03188223 |
| 43 | PKN2 | 1.02662767 |
| 44 | PTK2 | 1.02131036 |
| 45 | LATS2 | 1.00048996 |
| 46 | MAPKAPK3 | 0.99807860 |
| 47 | LATS1 | 0.99277416 |
| 48 | PDGFRA | 0.98881511 |
| 49 | CASK | 0.98385392 |
| 50 | TNK2 | 0.96146479 |
| 51 | TESK1 | 0.96124570 |
| 52 | CAMK1 | 0.94264918 |
| 53 | SGK3 | 0.94220481 |
| 54 | MAPK15 | 0.94052648 |
| 55 | MAP2K4 | 0.93320054 |
| 56 | EPHB1 | 0.92647305 |
| 57 | ERBB4 | 0.91512964 |
| 58 | NTRK1 | 0.89434732 |
| 59 | PDK2 | 0.87779010 |
| 60 | MAP2K1 | 0.87393772 |
| 61 | MAP2K2 | 0.87383493 |
| 62 | FGFR3 | 0.85989545 |
| 63 | LIMK1 | 0.85494295 |
| 64 | MAPK13 | 0.85487425 |
| 65 | DDR2 | 0.84404498 |
| 66 | FGR | 0.84154282 |
| 67 | BMX | 0.84012890 |
| 68 | MARK2 | 0.81781351 |
| 69 | PRKCG | 0.81174640 |
| 70 | PRKCE | 0.81146020 |
| 71 | FGFR4 | 0.80679232 |
| 72 | PDPK1 | 0.80402149 |
| 73 | PTK2B | 0.76821308 |
| 74 | ROCK1 | 0.72331145 |
| 75 | PAK4 | 0.71875542 |
| 76 | CAMK2G | 0.71839462 |
| 77 | MAPK12 | 0.71527719 |
| 78 | FGFR2 | 0.70957785 |
| 79 | PRKG2 | 0.70476589 |
| 80 | MET | 0.69211544 |
| 81 | MINK1 | 0.68197594 |
| 82 | MAP3K7 | 0.67619351 |
| 83 | DAPK3 | 0.67369355 |
| 84 | KSR2 | 0.67310213 |
| 85 | RET | 0.66007075 |
| 86 | WNK4 | 0.65293296 |
| 87 | STK38 | 0.64635325 |
| 88 | CDK5 | 0.64098162 |
| 89 | FGFR1 | 0.63788425 |
| 90 | MAPK10 | 0.62742096 |
| 91 | STK39 | 0.62701008 |
| 92 | PRKD1 | 0.61473172 |
| 93 | PDK1 | 0.61315286 |
| 94 | MAP3K13 | 0.60944090 |
| 95 | CAMK2A | 0.60802457 |
| 96 | CDK15 | 0.60265148 |
| 97 | PINK1 | 0.58889594 |
| 98 | FES | 0.56257809 |
| 99 | LRRK2 | 0.56254611 |
| 100 | MST1R | 0.55408599 |
| 101 | CDK18 | 0.55257014 |
| 102 | CDK14 | 0.55162644 |
| 103 | PRKCH | 0.55022977 |
| 104 | ICK | 0.54987844 |
| 105 | PRKG1 | 0.54712366 |
| 106 | RPS6KA3 | 0.51650791 |
| 107 | CDC42BPA | 0.50880533 |
| 108 | MAPKAPK5 | 0.49891519 |
| 109 | CDK11A | 0.49102662 |
| 110 | ALK | 0.49043795 |
| 111 | CAMK2B | 0.47943305 |
| 112 | CAMKK1 | 0.47517249 |
| 113 | PRPF4B | 0.47346742 |
| 114 | ROCK2 | 0.46834982 |
| 115 | MAPK7 | 0.46452127 |
| 116 | HIPK2 | 0.46310376 |
| 117 | WNK3 | 0.45463790 |
| 118 | SGK1 | 0.45422676 |
| 119 | CAMK2D | 0.43523791 |
| 120 | DYRK1A | 0.42977346 |
| 121 | CAMKK2 | 0.42533091 |
| 122 | ADRBK1 | 0.42126093 |
| 123 | PRKACA | 0.42041165 |
| 124 | STK38L | 0.41817772 |
| 125 | JAK1 | 0.41482136 |
| 126 | ERBB2 | 0.41013906 |
| 127 | STK11 | 0.39775707 |
| 128 | CSNK1G2 | 0.38712307 |
| 129 | PRKCA | 0.37920970 |
| 130 | PRKACG | 0.37789117 |
| 131 | PRKCZ | 0.37507447 |
| 132 | SRC | 0.37114862 |
| 133 | IGF1R | 0.36989997 |
| 134 | MAP2K6 | 0.34849197 |
| 135 | FYN | 0.33959836 |
| 136 | DAPK1 | 0.33908663 |
| 137 | DMPK | 0.33286105 |
| 138 | INSRR | 0.32751250 |
| 139 | TAOK2 | 0.31303046 |
| 140 | PRKCQ | 0.28679138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.71243669 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.45949399 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.06003502 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.97137905 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.93927111 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.73686772 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.43517705 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35842743 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08259524 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03963819 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03090771 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77538473 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74828711 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.71356722 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68339163 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65369347 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64626602 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.57776208 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52857425 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50995721 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50101471 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49090280 |
| 23 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47082294 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44867709 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42939609 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.36736016 |
| 27 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35970819 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31176894 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29672727 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21051678 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18872576 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16292104 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12267601 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09564170 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07918147 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07723826 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06013731 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02449736 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01926967 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00627369 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00575733 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99884894 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98160634 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96129103 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91487167 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90484454 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89650162 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86858725 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86656611 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 0.83889017 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83519565 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83336753 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83141262 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 0.82498329 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81302965 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81026499 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80285830 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.78604671 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76915422 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76633354 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.76609728 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76599178 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75316231 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75295865 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73776536 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73616933 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.73578962 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73188964 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.73005277 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72296462 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72030872 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70930864 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.69513802 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.67901917 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66662951 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65220832 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65152267 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64590564 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63961024 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63786948 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62230698 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61808674 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61119815 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60939957 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60670614 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60663636 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59891773 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59801345 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59667649 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58708558 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57719303 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57696754 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57374089 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56411597 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54036055 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52977898 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51300006 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50401087 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49787346 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.49231891 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48680804 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.48333257 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48275343 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48078754 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47953317 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47573549 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44199366 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43591382 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41393415 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40938467 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40530483 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40386102 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.40340913 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40310781 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39992942 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38671735 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.38213053 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37823300 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37680080 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35471742 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35030287 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.33975804 |
| 123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.32720040 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.32687597 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.32075960 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31532434 |
| 127 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31043060 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30647385 |
| 129 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30456713 |
| 130 | Melanogenesis_Homo sapiens_hsa04916 | 0.28161616 |
| 131 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28040059 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27875114 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.27848005 |
| 134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26247303 |
| 135 | Lysosome_Homo sapiens_hsa04142 | 0.25789971 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.25768494 |

